Recent Finacing
Recent Raise
Bioxodes is a Gosselies-based clinical-stage biopharmaceutical company developing BIOX-101, a dual anticoagulant and anti-inflammatory therapy for thrombotic and inflammatory conditions.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
